Carl Jung liking parting life Carl Jung

I Was Part of a 'Magic Mushrooms' Drug Trial for Treatment-Resistant Depression

Reading now: 175

In 2020, I took part in a psilocybin trial. Psilocybin is the psychedelic ingredient found in magic mushrooms. The trial was carried out at a London hospital and designed to study the potential benefits of psilocybin for treatment-resistant depression — a condition I have struggled with for 55 years.

The program consisted of five therapy sessions, a single dosing day, then six weeks of integration therapy where I discussed, with the therapist, my psilocybin experience.

The research team running the study were young, forward-thinking psychiatrists, neuroscientists, and therapists — all of whom were into meditation, holotropic breathwork, and the ideas of Carl Jung.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles